Arcam is since April 11, 2013 certified to the Quality Management System Standard ISO 9001:2008. Our clients can be assured that we will fully stand behind our quality promise. Our ISO certification guarantees that our proven, accountable system will consistently …
Arcam’s business is growing and so do our premises at Arcam HQ in Sweden. Over 400 m2 floor space have been added, mainly for production. The existing production area has also undergone extensive changes. We now have appropriate facilities to …
Arcam’s new EBM system, Arcam Q10, is developed in close collaboration with leading implant manufacturers. The development is partly financed by Vinnova. The system is designed to meet the implant industry’s need for ease-of-use, productivity, accuracy and quality assurance. Arcam …
Arcam AB listed on NASDAQ OMX and market leader in EBM-based Additive Manufacturing technology, today announced that management is scheduled to participate at the Piper Jaffray Technology, Media & Telecommunications Conference at the Le Parker Meridien in New York on March …
The partnership combines leading Additive Manufacturing technology with full-service product application development and contract manufacturing services. Arcam AB (“Arcam”), listed on NASDAQ OMX and market leader in EBM-based Additive Manufacturing technology, has signed a strategic alliance agreement with DiSanto Technology …
Arcam and Oak Ridge National Laboratory (ORNL), Tennessee, US, has signed a co-operation agreement under which the parties will facilitate the introduction of Arcam’s EBM technology to US industry through a Manufacturing Demonstration Facility (MDF). ORNL purchased its first Arcam …
June 7, 2012, the leaders of the governing parties visited Arcam headquarters in Mölndal as part of the work on the Commission on the Future (Framtidskommissionen). The Commission consists of a constellation of the most powerful politicians in Sweden. Their …
NASDAQ OMX Stockholm’s Listing Committee has approved Arcam AB for listing on NASDAQ OMX Stockholm, Small Cap. The first day of trading on NASDAQ OMX Stockholm will be June 18, 2012 and the last day of trading on NGM Equity …
Arcam recently released 50 µm process. The reduced layer thickness improves resolution and surface finish, whilst maintaining the EBM technology’s core benefits – high productivity and excellent material properties.
U.S. implant manufacturers have recently received FDA’s clearance for products manufactured with Arcam’s EBM® technology. With the FDA clearance the companies are allowed to market their products on the important U.S. market. The U.S. market for orthopaedic implants represents about …
